0001209191-17-049974.txt : 20170823
0001209191-17-049974.hdr.sgml : 20170823
20170823165659
ACCESSION NUMBER: 0001209191-17-049974
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170821
FILED AS OF DATE: 20170823
DATE AS OF CHANGE: 20170823
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Carter Martha J.
CENTRAL INDEX KEY: 0001213040
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33451
FILM NUMBER: 171047590
MAIL ADDRESS:
STREET 1: C/O AEGERION PHARMACEUTICALS, INC.
STREET 2: 89 HEADQUARTERS PLAZA, SUITE 1212
CITY: MORRISTOWN
STATE: NJ
ZIP: 07960
FORMER NAME:
FORMER CONFORMED NAME: CARTER MARTHA J
DATE OF NAME CHANGE: 20030106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALBIREO PHARMA, INC.
CENTRAL INDEX KEY: 0001322505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 857-415-4774
MAIL ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: Biodel Inc
DATE OF NAME CHANGE: 20050331
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-08-21
0
0001322505
ALBIREO PHARMA, INC.
ALBO
0001213040
Carter Martha J.
C/O ALBIREO PHARMA, INC.
10 POST OFFICE SQUARE, SUITE 502 SOUTH
BOSTON
MA
02109
0
1
0
0
Chief Regulatory Officer
Stock Option (right to buy)
24.48
2017-08-21
4
A
0
13000
0.00
A
2027-08-20
Common Stock
13000
13000
D
This option will vest and become exercisable in equal installments on the last day of 16 consecutive calendar quarters beginning with September 30, 2017 and ending on June 30, 2021.
/s/ Peter A. Zorn, Attorney-in-fact for Martha J. Carter
2017-08-23